Merz Therapeutics buying two drugs for $185 million
One of the drugs is for the treatment of “off” phases of Parkinson’s disease called Inbrija. The other drug is for the treatment of gait disorders in multiple sclerosis called Ampyra.
Read More
drug discovery
UNC seeks $125M to discover new drugs against future pandemic
The Rapidly Emerging Antiviral Drug Development Initiative (READDI) involves researchers from the UNC School of Medicine, the UNC Eshelman School of Pharmacy, and the UNC Gillings School of Global Public Health.
Read More
